Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.
Anstey
A
A
Department of Dermatology, University Hospital of Wales, Cardiff, UK.
D001379:Azathioprine / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003376:Counseling; D006801:Humans; D015122:Mercaptopurine / Q000378:metabolism; D008745:Methylation; D008780:Methyltransferases / Q000172:deficiency; D012871:Skin Diseases / Q000188:drug therapy*; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy
D015122:Mercaptopurine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine